Australia’s drug landscape is changing faster than many workplaces realise. While familiar substances like cannabis, methamphetamines and cocaine remain common, a new wave of synthetic and prescription‑based drugs is increasingly being used — often by people who don’t consider themselves “drug users”.
These emerging substances can create significant impairment, yet many fall outside standard workplace drug screening methods. This creates a growing safety gap between what workplaces test for and what workers may be using.
The New Substances Reshaping Workplace Risk
A range of emerging drugs is now contributing to impairment in Australian workplaces:
- Synthetic cannabinoids (K2, Spice, herbal blends) — Marketed as “legal highs”, these substances can cause severe impairment, anxiety and unpredictable reactions.
- Designer stimulants (bath salts, cathinones, NPS stimulants) — These mimic amphetamines or MDMA but vary widely in potency, often causing agitation, overheating and erratic behaviour.
- Misused prescription medicines — ADHD medication, medicinal cannabis, sleeping tablets and other prescription drugs are safe when taken as directed, but misuse can impair judgment and increase risk‑taking.
- Emerging benzodiazepines and synthetic opioids — New compounds appear regularly through online markets, depressing the central nervous system and reducing coordination and alertness.
The Detection Gap: What Screening Can and Cannot Identify
Workplace drug screening is highly effective for traditional substances such as cannabis, methamphetamine, cocaine and certain prescription medications.
However, many emerging drugs fall outside validated testing panels.
Synthetic cannabinoids frequently change chemical structure, making them difficult to detect. Designer stimulants and many novel psychoactive substances (NPS) also evade standard screening. This does not mean testing is ineffective — but it does mean workplaces must understand that testing is only one part of a broader fit for work framework.
What Employers Need to Do Now
To stay ahead of emerging drug trends, workplaces should strengthen:
- Policy clarity — Ensure your drug and alcohol policy covers synthetic and emerging substances.
- Supervisor capability — Train supervisors to recognise behavioural signs of impairment.
- Education — Correct misconceptions about “legal highs” and prescription misuse.
- Testing pathways — Use saliva testing for recent use and impairment.
- Culture — Reinforce that fitness for work is a shared responsibility.
The Bottom Line
Drug markets evolve quickly — and workplace safety systems must evolve with them. Emerging substances create real impairment risks, even when they fall outside standard screening. By strengthening policy, supervision, education and culture, workplaces can stay ahead of these trends and protect the safety of everyone on site.
Read the Full Newsletter.
